Yao JC - Search Results

1

Telotristat etiprate, a novel serotonin synthesis inhibitor, in patients with carcinoid syndrome and diarrhea not adequately controlled by octreotide.

Kulke MH, O'Dorisio T, Phan A, Bergsland E, Law L, Banks P, Freiman J, Frazier K, Jackson J, Yao JC, Kvols L, Lapuerta P, Zambrowicz B, Fleming D, Sands A. Kulke MH, et al. Among authors: yao jc. Endocr Relat Cancer. 2014 Oct;21(5):705-14. doi: 10.1530/ERC-14-0173. Epub 2014 Jul 10. Endocr Relat Cancer. 2014. PMID: 25012985 Free PMC article. Clinical Trial.

2

Multicenter phase II trial of S-1 plus cisplatin in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma.

Ajani JA, Lee FC, Singh DA, Haller DG, Lenz HJ, Benson AB 3rd, Yanagihara R, Phan AT, Yao JC, Strumberg D. Ajani JA, et al. Among authors: yao jc. J Clin Oncol. 2006 Feb 1;24(4):663-7. doi: 10.1200/JCO.2005.04.2994. J Clin Oncol. 2006. PMID: 16446338 Clinical Trial.

3

Antitumor activity of rapamycin and octreotide as single agents or in combination in neuroendocrine tumors.

Moreno A, Akcakanat A, Munsell MF, Soni A, Yao JC, Meric-Bernstam F. Moreno A, et al. Among authors: yao jc. Endocr Relat Cancer. 2008 Mar;15(1):257-66. doi: 10.1677/ERC-07-0202. Endocr Relat Cancer. 2008. PMID: 18310292

4

Targeting vascular endothelial growth factor in advanced carcinoid tumor: a random assignment phase II study of depot octreotide with bevacizumab and pegylated interferon alpha-2b.

Yao JC, Phan A, Hoff PM, Chen HX, Charnsangavej C, Yeung SC, Hess K, Ng C, Abbruzzese JL, Ajani JA. Yao JC, et al. J Clin Oncol. 2008 Mar 10;26(8):1316-23. doi: 10.1200/JCO.2007.13.6374. J Clin Oncol. 2008. PMID: 18323556 Clinical Trial.

5

Family history of cancer and associated risk of developing neuroendocrine tumors: a case-control study.

Hassan MM, Phan A, Li D, Dagohoy CG, Leary C, Yao JC. Hassan MM, et al. Among authors: yao jc. Cancer Epidemiol Biomarkers Prev. 2008 Apr;17(4):959-65. doi: 10.1158/1055-9965.EPI-07-0750. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18398037

6

Risk factors associated with neuroendocrine tumors: A U.S.-based case-control study.

Hassan MM, Phan A, Li D, Dagohoy CG, Leary C, Yao JC. Hassan MM, et al. Among authors: yao jc. Int J Cancer. 2008 Aug 15;123(4):867-73. doi: 10.1002/ijc.23529. Int J Cancer. 2008. PMID: 18491401

7

One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.

Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, Abdalla EK, Fleming JB, Vauthey JN, Rashid A, Evans DB. Yao JC, et al. J Clin Oncol. 2008 Jun 20;26(18):3063-72. doi: 10.1200/JCO.2007.15.4377. J Clin Oncol. 2008. PMID: 18565894 Review.

8

Efficacy of RAD001 (everolimus) and octreotide LAR in advanced low- to intermediate-grade neuroendocrine tumors: results of a phase II study.

Yao JC, Phan AT, Chang DZ, Wolff RA, Hess K, Gupta S, Jacobs C, Mares JE, Landgraf AN, Rashid A, Meric-Bernstam F. Yao JC, et al. J Clin Oncol. 2008 Sep 10;26(26):4311-8. doi: 10.1200/JCO.2008.16.7858. J Clin Oncol. 2008. PMID: 18779618 Free PMC article. Clinical Trial.

9

Octreotide LAR in carcinoid: how to dose?

Yao JC, Kvols LK. Yao JC, et al. Pancreas. 2008 Oct;37(3):337-8; author reply 338-9. doi: 10.1097/MPA.0b013e31818adf4b. Pancreas. 2008. PMID: 18815562 No abstract available.

10

Treatment options for metastatic neuroendocrine tumors.

Phan AT, Yao JC, Evans DB. Phan AT, et al. Among authors: yao jc. Surgery. 2008 Dec;144(6):895-8. doi: 10.1016/j.surg.2008.10.003. Surgery. 2008. PMID: 19040994 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

313 results

Search Page

Filters